Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'clopidogrel' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 159 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kalaria, VG; Ling, FS
      Late stent thrombosis without antecedent brachytherapy: Confirmation and treatment with rheolytic thrombectomy

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Zurbrugg, HR; Musci, M; Sanger, S; Gutersohn, A; Mulling, C; Wellnhofer, E; Schaffner, T; Hetzer, R
      Prevention of venous graft sclerosis with clopidogrel and aspirin combinedwith a mesh tubing in a dog model of arteriovenous bypass grafting

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    3. Santillan, MKO; Herring, J; Hoppensteadt, DA; Jeske, W; Herbert, JM; Fareed, J
      The effect of a novel glycoprotein IIb/IIIa antagonist, SR 121566A, on platelet aggregation and activation in rhesus monkeys

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    4. Reinisch, CM; Dunzendorfer, S; Pechlaner, C; Ricevuti, G; Wiedermann, CJ
      The inhibition of oxygen radical release from human neutrophil by resting platelets is reversed by administration of acetylsalicylic acid or clopidogrel

      FREE RADICAL RESEARCH
    5. El-Beyrouty, C; Spinler, SA
      Cilostazol for prevention of thrombosis and restenosis after intracoronarystenting

      ANNALS OF PHARMACOTHERAPY
    6. Majid, A; Delanty, N; Kantor, J
      Antiplatelet agents for secondary prevention of ischemic stroke

      ANNALS OF PHARMACOTHERAPY
    7. Bogousslavsky, J
      Benefit of ADP receptor antagonists in atherothrombotic patients: New evidence

      CEREBROVASCULAR DISEASES
    8. Yadav, JS
      Management practices in carotid stenting

      CEREBROVASCULAR DISEASES
    9. Easton, JD
      Future perspectives for optimizing oral antiplatelet therapy

      CEREBROVASCULAR DISEASES
    10. Bornstein, NM
      Antiplatelet drugs: How to select them and possibilities of combined treatment

      CEREBROVASCULAR DISEASES
    11. Scarborough, RM; Laibelman, AM; Clizbe, LA; Fretto, LJ; Conley, PB; Reynolds, EE; Sedlock, DM; Jantzen, HM
      Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12))

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    12. Maayani, S; Tagliente, TM; Schwarz, T; Craddock-Royal, B; Alcala, C; Marrero, G; Martinez, R
      Deaggregation is an integral component of the response of platelets to ADPin vitro: kinetic studies of literature and original data

      PLATELETS
    13. Maayani, S; Tagliente, TM; Schwarz, T; Martinelli, G; Martinez, R; Shore-Lesserson, L
      The balance of concurrent aggregation and deaggregation processes in platelets is linked to differential occupancy of ADP receptor subtypes

      PLATELETS
    14. Maayani, S; Schwarz, T; Martinez, R; Tagliente, TM
      Activation of G(i)-coupled receptors releases a tonic state of inhibited platelet aggregation

      PLATELETS
    15. Ziegler, V; Schlesinger, S; Griewing, B; Samland, O
      Bleeding complications in combined treatment with clopidrogel and low-doseheparin in stroke patients

      PERFUSION
    16. Sugio, Y; Okamura, T; Shimoda, K; Matsumoto, M; Yagi, H; Ishizashi, H; Niho, Y; Inaba, S; Fujimura, Y
      Ticlopidine-associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    17. Calvin, JE; Klein, LW
      The use of antiplatelet agents in acute cardiac care

      CRITICAL CARE CLINICS
    18. Schuhlen, H; Kastrati, A; Pache, J; Dirschinger, J; Schomig, A
      Incidence of thrombotic occlusion and major adverse cardiac events betweentwo and four weeks after coronary stent placement: Analysis of 5,678 patients with a four-week ticlopidine regimen

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    19. Scrutinio, D; Cimminiello, C; Marubini, E; Pitzalis, MV; Di Biase, M; Rizzon, P
      Ticlopidine versus aspirin after myocardial infarction (STAMI) trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    20. Cattaneo, M; Gachet, C
      The platelet ADP receptors

      HAEMATOLOGICA
    21. Poele, JAMT; Van Kleef, EM; Van der Wal, AF; Dewit, LGH; Stewart, FA
      Radiation-induced glomerular thrombus formation and nephropathy are not prevented by the ADP receptor antagonist clopidogrel

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    22. Lowe, HC; Kumar, RK; Chesterman, CN; Fahmy, RG; Khachigian, LM
      Coronary stent thrombosis: Insights from the porcine coronary stent model

      THROMBOSIS AND HAEMOSTASIS
    23. Eckly, A; Gendrault, JL; Hechler, B; Cazenave, JP; Gachet, C
      Differential involvement of the P2Y(1) and P2Y(T) receptors in the morphological changes of platelet aggregation

      THROMBOSIS AND HAEMOSTASIS
    24. Storey, RF; Oldroyd, KG; Wilcox, RG
      Open multicentre study of the P-2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes

      THROMBOSIS AND HAEMOSTASIS
    25. Weber, AA; Braun, M; Hohlfeld, T; Schwippert, B; Tschope, D; Schror, K
      Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    26. Valentin, V
      Clopidogrel in acute coronary syndromes with non-ST elevation. Clinical implications of CURE trial

      REVISTA ESPANOLA DE CARDIOLOGIA
    27. Swanson, N; Hogrefe, K; Lloyd, AS; Gershlick, A
      Current perspectives on British use of adjunctive therapies during coronary interventions

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    28. Amoroso, G; van Boven, AJ; van Veldhuisen, DJ; Tio, RA; Balje-Volkers, CP; Petronio, AS; van Oeveren, W
      Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients withcoronary artery disease

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    29. Thurmann, PA
      Methods and systems to detect adverse drug reactions in hospitals

      DRUG SAFETY
    30. Hollopeter, G; Jantzen, HM; Vincent, D; Li, G; England, L; Ramakrishnan, V; Yang, RB; Nurden, P; Nurden, A; Julius, D; Conley, PB
      Identification of the platelet ADP receptor targeted by antithrombotic drugs

      NATURE
    31. Foster, CJ; Prosser, DM; Agans, JM; Zhai, Y; Smith, MD; Lachowicz, JE; Zhang, FL; Gustafson, E; Monsma, FJ; Wiekowski, MT; Abbondanzo, SJ; Cook, DN; Bayne, ML; Lira, SA; Chintala, MS
      Molecular identification and characterization of the platelet ADP receptortargeted by thienopyridine antithrombotic drugs

      JOURNAL OF CLINICAL INVESTIGATION
    32. Baurand, A; Raboisson, P; Freund, M; Leon, C; Cazenave, JP; Bourguignon, JJ; Gachet, C
      Inhibition of platelet function by administration of MRS2179, a P2Y(1) receptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    33. Leon, C; Freund, M; Ravanat, C; Baurand, A; Cazenave, JP; Gachet, C
      Key role of the P2Y(1) receptor in tissue factor-Induced thrombin-dependent acute thromboembolism - Studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist

      CIRCULATION
    34. Steinhubl, SR; Ellis, SG; Wolski, K; Lincoff, AM; Topol, EJ
      Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - Data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) trial

      CIRCULATION
    35. Reichenberger, F; Wirtz, H; Paschke, R
      Clopidogrel and side effects

      CARDIOLOGY
    36. Zhao, L; Bath, P; Heptinstall, S
      Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro

      BRITISH JOURNAL OF PHARMACOLOGY
    37. Sugidachi, A; Asai, F; Yoneda, K; Iwamura, R; Ogawa, T; Otsuguro, K; Koike, H
      Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747

      BRITISH JOURNAL OF PHARMACOLOGY
    38. Savi, P; Labouret, C; Delesque, N; Guette, F; Lupker, J; Herbert, JM
      P2Y(12), a new platelet ADP receptor, target of clopidogrel

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    39. Spannagl, M; Frey, L
      New antiplatelet drugs

      ANAESTHESIST
    40. Berger, PB; Dzavik, V; Penn, IM; Catellier, D; Buller, CE
      Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA)

      AMERICAN HEART JOURNAL
    41. Dillon, WC; Eckert, GJ; Dillon, JC; Ritchie, ME
      Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    42. Kolansky, DM; Klugherz, BD; Curran, SC; Herrmann, HC; Magness, K; Wilensky, RL; Hirshfeld, JW
      Combination therapy with clopidogrel and aspirin after coronary stenting

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    43. Rupprecht, HJ
      Adenosine diphosphate receptor antagonists: from pharmacology to clinical practice

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    44. Liu, LS; Collins, R; Chen, ZM; Xie, JX; Jiang, LX; Wang, W; Pan, HC; Peto, R; Tao, SQ; Gong, LS; Hui, RT; Huang, TG; Zeng, DY; Chen, YZ; Liu, YH; Qian, TJ; Xu, CB; Dai, GZ; Feng, JZ; Cai, NS; Hu, DY; Huang, J; Li, TD; Li, YQ; Wang, LH; Yang, DC; Zhu, J; Zhu, DQ; Zhou, JC; Yang, XF; Cui, JJ; Jiang, BQ; Yin, JQ; San, J; Huang, DJ; Xi, WH; Fu, SY; Chen, YP; Gent, M
      Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction

      JOURNAL OF CARDIOVASCULAR RISK
    45. Elneairy, MAA; Eldin, SM; Attaby, FA; El-Louh, AKK
      Cyanothioacetamide in heterocyclic chemistry: Synthesis of thiopyran, pyridinethione, thienopyridine, pyridothienotriazine and pyridothienopyrimidinederivatives

      PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS
    46. Bhatt, DL; Kapadia, SR; Yadav, JS; Topol, EJ
      Update on clinical trials of antiplatelet therapy for cerebrovascular diseases

      CEREBROVASCULAR DISEASES
    47. Weksler, BB
      Antiplatelet agents in stroke prevention - Combination therapy: Present and future

      CEREBROVASCULAR DISEASES
    48. Paciaroni, M; Gallai, V
      Antiplatelet agents for stroke prevention

      CEREBROVASCULAR DISEASES
    49. Moore, SA; Steinhubl, SR
      Clopidogrel and coronary stenting: What is the next question?

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    50. Kaufman, JS; Fiore, L; Hasbargen, JA; O'Connor, TZ; Perdriset, G
      A pharmacodynamic study of clopidogrel in chronic hemodialysis patients

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    51. Becker, RC
      Platelet surface physiology and its importance in pharmacotherapy design and development: The adenosine diphosphate receptor antagonists

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    52. Gryglewski, RJ; Dupin, JP; Uracz, W; Swies, J; Madej, J; Hou, G; Gravier, D; Casadebaig, F
      Thrombolysis by thienopyridines and their congeners

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    53. Burgos, A; Herbert, JM; Simpson, I
      ortho-metalation/chlorination of benzoic acid derivatives: Preparation of [benzene-U-C-13]-rac-Clopidogrel ([benzene-U-C-13]-rac-SR25990C).

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    54. Savi, P; Pereillo, JM; Uzabiaga, MF; Combalbert, J; Picard, C; Maffrand, JP; Pascal, M; Herbert, JM
      Identification and biological activity of the active metabolite of clopidogrel

      THROMBOSIS AND HAEMOSTASIS
    55. Baurand, A; Eckly, A; Bari, N; Leon, C; Hechler, B; Cazenave, JP; Gachet, C
      Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y(1) and P2cyc receptors

      THROMBOSIS AND HAEMOSTASIS
    56. Wittke, B; Ensor, H; Chung, J; Birnbock, H; Lausecker, B; Ertel, SI; Mackie, IJ; Machin, SJ
      Pharmacokinetics and pharmacodynamics of sibrafiban alone or in combination with ticlopidine and aspirin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    57. Alter, P; Schaefer, JR; Maisch, B
      Impediment of the cellular immune response under treatment with ticlopidine in aortic valve endocarditis caused by Staphylococcus aureus

      ZEITSCHRIFT FUR KARDIOLOGIE
    58. Takahashi, O
      Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis

      FOOD AND CHEMICAL TOXICOLOGY
    59. De Feyter, PJ; Foley, D
      Coronary stent implantation: a panacea for the interventional cardiologist?

      EUROPEAN HEART JOURNAL
    60. Phatouros, CC; Lefler, JE; Higashida, RT; Meyers, PM; Malek, AM; Dowd, CF; Halbach, VV
      Primary stenting for high-grade basilar artery stenosis

      AMERICAN JOURNAL OF NEURORADIOLOGY
    61. Tong, FC; Cloft, HJ; Joseph, GJ; Samuels, OB; Dion, JE
      Abciximab rescue in acute carotid stent thrombosis

      AMERICAN JOURNAL OF NEURORADIOLOGY
    62. King, SB
      Optimizing antiplatelet therapy in coronary interventions

      CLINICAL CARDIOLOGY
    63. Montalescot, G
      Value of antiplatelet therapy in preventing thrombotic events in generalized vascular disease

      CLINICAL CARDIOLOGY
    64. Topol, EJ
      The future of antiplatelet therapy: Optimizing management in patients withacute coronary syndrome

      CLINICAL CARDIOLOGY
    65. Qureshi, AI; Luft, AR; Sharma, M; Guterman, LR; Hopkins, LN
      Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I - Pathophysiological and pharmacological features

      NEUROSURGERY
    66. Goette, A; Ittenson, A; Hoffmanns, P; Reek, S; Hartung, W; Klein, H; Ansorge, S; Geller, JC
      Increased expression of P-selectin in patients with chronic atrial fibrillation

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    67. Reist, M; Roy-De Vos, M; Montseny, JP; Mayer, JM; Carrupt, PA; Berger, Y; Testa, B
      Very slow chiral inversion of clopidogrel in rats: A pharmacokinetic and mechanistic investigation

      DRUG METABOLISM AND DISPOSITION
    68. Giardino, EC; Costanzo, MJ; Kauffman, JA; Li, QS; Maryanoff, BE; Andrade-Gordon, P
      Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor

      THROMBOSIS RESEARCH
    69. Fork, FT; Lafolie, P; Toth, E; Lindgarde, F
      Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers - A gastroscopic study

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    70. Link, J; Manke, C; Rosin, L; Borisch, I; Topel, I; Horn, M; Mann, S; Jauch, KW; Bogdahn, U; Feuerbach, S; Kasprzak, P
      Carotid endarteriectomy and carotic stenting. Pilot study of a prospective, randomized and controlled comparison

      RADIOLOGE
    71. Nickolaus, MJ; Chambers, CE; Ettinger, SM; Gilchrist, IC; Kozak, M
      Advances in interventional cardiology - Beyond the balloon

      NURSING CLINICS OF NORTH AMERICA
    72. Slavina, NN; Averkov, OV; Gratsiansky, NA
      Unstable angina. Short term treatment with clopidogrel with the use of a loading dose: Effect on ADP-induced platelet aggregation

      KARDIOLOGIYA
    73. Takamatsu, H; Tsukada, H; Kakiuchi, T; Tatsumi, M; Umemura, K
      Changes in local cerebral blood flow in photochemically induced thromboticocclusion model in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    74. Jarvis, B; Simpson, K
      Clopidogrel - A review of its use in the prevention of atherothrombosis

      DRUGS
    75. Muller, C; Buttner, HJ; Petersen, J; Roskamm, H
      A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents

      CIRCULATION
    76. Sugidachi, A; Asai, F; Ogawa, T; Inoue, T; Koike, H
      The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties

      BRITISH JOURNAL OF PHARMACOLOGY
    77. Jarvis, GE; Humphries, RG; Robertson, MJ; Leff, P
      ADP can induce aggregation of human platelets via both P2Y(1) and P-2T receptors

      BRITISH JOURNAL OF PHARMACOLOGY
    78. Steinhubl, SR
      Antiplatelet agents in cardiology: The choice of therapy

      ANNALS OF THORACIC SURGERY
    79. Keser, C
      Antiplatelet agents in spinal anesthesia

      ANAESTHESIST
    80. King, SP
      Interventions in cardiology: What does and does not work

      AMERICAN JOURNAL OF CARDIOLOGY
    81. Nenci, GG
      Unifying concept of arterial vascular disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    82. Herbert, JM; Savi, P; Maffrand, JP
      Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    83. Cattaneo, M; Gachet, C
      ADP receptors and clinical bleeding disorders

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    84. Zeolla, MM; Carson, JJ
      Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity

      ANNALS OF PHARMACOTHERAPY
    85. Gurbel, PA; O'Connor, CM; Cummings, CC; Serebruany, VL
      Clopidogrel: The future choice for preventing platelet activation during coronary stenting?

      PHARMACOLOGICAL RESEARCH
    86. Hagberg, IA; Solvik, UO; Opdahl, H; Roald, HE; Lyberg, T
      Inhalation of nitric oxide inhibits ADP-induced platelet aggregation and alpha-granule release

      PLATELETS
    87. Ziemianin, B; Olszanecki, R; Uracz, W; Marcinkiewicz, E; Gryglewski, RJ
      Thienopyridines: Effects on cultured endothelial cells

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    88. David, JL; Limet, R
      Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients

      THROMBOSIS AND HAEMOSTASIS
    89. Leon, C; Vial, C; Gachet, C; Ohlmann, P; Hechler, B; Cazenave, JP; Lecchi, A; Cattaneo, M
      The P2Y(1) receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation - Further evidence for a distinct P2 receptor responsible for adenylyl cyclase inhibition

      THROMBOSIS AND HAEMOSTASIS
    90. Taka, T; Okano, E; Seki, J; Yamamoto, J
      Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress

      HAEMOSTASIS
    91. Nenci, GG
      Unifying concept of arterial vascular disease

      EUROPEAN HEART JOURNAL
    92. Herbert, JM; Savi, P; Maffrand, JP
      Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist

      EUROPEAN HEART JOURNAL
    93. Wilson, JM; Ferguson, JJ
      Platelet-endothelial interactions in atherothrombotic disease: Therapeuticimplications

      CLINICAL CARDIOLOGY
    94. Bernat, A; Hoffmann, P; Savi, P; Lale, A; Herbert, JM
      Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GP IIb IIIa antagonist

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    95. Savcic, M; Hauert, J; Bachmann, F; Wyld, PJ; Geudelin, B; Cariou, R
      Clopidogrel loading dose regimens: Kinetic profile of pharmacodynamic response in healthy subjects

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    96. Caplain, H; Cariou, R
      Long-term activity of clopidogrel: A three-month appraisal in healthy volunteers

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    97. Caplain, H; Donat, F; Gaud, C; Necciari, J
      Pharmacokinetics of clopidogrel

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    98. Lins, R; Broekhuysen, J; Necciari, J; Deroubaix, X
      Pharmacokinetic profile of C-14-labeled clopidogrel

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    99. Pierce, CH; Houle, JM; Dickinson, JP; Kindermans, M; Serre-Lacroix, E; Kieffer, G; Necciari, J
      Clopidogrel and drug metabolism: Absence of effect on hepatic enzymes in healthy volunteers

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    100. McEwen, J; Strauch, G; Perles, P; Pritchard, G; Moreland, TE; Necciari, J; Dickinson, JP
      Clopidogrel bioavailability: Absence of influence of food or antacids

      SEMINARS IN THROMBOSIS AND HEMOSTASIS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 05:20:04